nodes	percent_of_prediction	percent_of_DWPC	metapath
Methysergide—HTR1B—attention deficit hyperactivity disorder	0.473	0.658	CbGaD
Methysergide—HTR2A—attention deficit hyperactivity disorder	0.246	0.342	CbGaD
Methysergide—HTR7—locus ceruleus—attention deficit hyperactivity disorder	0.00896	0.112	CbGeAlD
Methysergide—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.00559	0.07	CbGeAlD
Methysergide—HTR7—autonomic nervous system—attention deficit hyperactivity disorder	0.00476	0.0597	CbGeAlD
Methysergide—HTR1F—forebrain—attention deficit hyperactivity disorder	0.00351	0.044	CbGeAlD
Methysergide—HTR1E—forebrain—attention deficit hyperactivity disorder	0.00304	0.0381	CbGeAlD
Methysergide—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.00297	0.0372	CbGeAlD
Methysergide—HTR6—forebrain—attention deficit hyperactivity disorder	0.00239	0.0299	CbGeAlD
Methysergide—HTR1F—nervous system—attention deficit hyperactivity disorder	0.00191	0.0239	CbGeAlD
Methysergide—HTR1F—central nervous system—attention deficit hyperactivity disorder	0.00184	0.023	CbGeAlD
Methysergide—HTR1E—nervous system—attention deficit hyperactivity disorder	0.00165	0.0207	CbGeAlD
Methysergide—HTR1E—central nervous system—attention deficit hyperactivity disorder	0.00159	0.0199	CbGeAlD
Methysergide—HTR1F—brain—attention deficit hyperactivity disorder	0.00146	0.0183	CbGeAlD
Methysergide—HTR1B—forebrain—attention deficit hyperactivity disorder	0.00144	0.018	CbGeAlD
Methysergide—HTR1D—forebrain—attention deficit hyperactivity disorder	0.00139	0.0175	CbGeAlD
Methysergide—HTR2C—forebrain—attention deficit hyperactivity disorder	0.00138	0.0173	CbGeAlD
Methysergide—HTR6—nervous system—attention deficit hyperactivity disorder	0.0013	0.0162	CbGeAlD
Methysergide—HTR2B—forebrain—attention deficit hyperactivity disorder	0.0013	0.0162	CbGeAlD
Methysergide—HTR1E—brain—attention deficit hyperactivity disorder	0.00126	0.0158	CbGeAlD
Methysergide—HTR6—central nervous system—attention deficit hyperactivity disorder	0.00125	0.0156	CbGeAlD
Methysergide—HTR1B—cardiovascular system—attention deficit hyperactivity disorder	0.00122	0.0153	CbGeAlD
Methysergide—HTR1D—cardiovascular system—attention deficit hyperactivity disorder	0.00118	0.0148	CbGeAlD
Methysergide—HTR1A—forebrain—attention deficit hyperactivity disorder	0.00116	0.0146	CbGeAlD
Methysergide—HTR7—forebrain—attention deficit hyperactivity disorder	0.00111	0.0139	CbGeAlD
Methysergide—HTR2B—cardiovascular system—attention deficit hyperactivity disorder	0.0011	0.0137	CbGeAlD
Methysergide—HTR6—brain—attention deficit hyperactivity disorder	0.00099	0.0124	CbGeAlD
Methysergide—HTR1A—cardiovascular system—attention deficit hyperactivity disorder	0.000982	0.0123	CbGeAlD
Methysergide—HTR1B—midbrain—attention deficit hyperactivity disorder	0.00095	0.0119	CbGeAlD
Methysergide—HTR7—cardiovascular system—attention deficit hyperactivity disorder	0.000938	0.0118	CbGeAlD
Methysergide—HTR1D—midbrain—attention deficit hyperactivity disorder	0.00092	0.0115	CbGeAlD
Methysergide—HTR2C—midbrain—attention deficit hyperactivity disorder	0.000911	0.0114	CbGeAlD
Methysergide—SIGMAR1—midbrain—attention deficit hyperactivity disorder	0.000858	0.0108	CbGeAlD
Methysergide—Lisuride—DRD5—attention deficit hyperactivity disorder	0.000853	0.0874	CrCbGaD
Methysergide—Lisuride—ADRA2C—attention deficit hyperactivity disorder	0.000804	0.0824	CrCbGaD
Methysergide—Bromocriptine—DRD5—attention deficit hyperactivity disorder	0.00079	0.0809	CrCbGaD
Methysergide—HTR1B—nervous system—attention deficit hyperactivity disorder	0.000781	0.00979	CbGeAlD
Methysergide—HTR1A—midbrain—attention deficit hyperactivity disorder	0.000767	0.00961	CbGeAlD
Methysergide—HTR1D—nervous system—attention deficit hyperactivity disorder	0.000756	0.00948	CbGeAlD
Methysergide—HTR1B—central nervous system—attention deficit hyperactivity disorder	0.000752	0.00943	CbGeAlD
Methysergide—HTR2C—nervous system—attention deficit hyperactivity disorder	0.000749	0.00939	CbGeAlD
Methysergide—Bromocriptine—ADRA2C—attention deficit hyperactivity disorder	0.000745	0.0763	CrCbGaD
Methysergide—HTR7—midbrain—attention deficit hyperactivity disorder	0.000733	0.00918	CbGeAlD
Methysergide—HTR1D—central nervous system—attention deficit hyperactivity disorder	0.000728	0.00913	CbGeAlD
Methysergide—HTR2C—central nervous system—attention deficit hyperactivity disorder	0.000721	0.00904	CbGeAlD
Methysergide—HTR2B—nervous system—attention deficit hyperactivity disorder	0.000703	0.00882	CbGeAlD
Methysergide—HTR2A—forebrain—attention deficit hyperactivity disorder	0.000692	0.00867	CbGeAlD
Methysergide—HTR2B—central nervous system—attention deficit hyperactivity disorder	0.000677	0.00849	CbGeAlD
Methysergide—SIGMAR1—cerebellum—attention deficit hyperactivity disorder	0.000663	0.00832	CbGeAlD
Methysergide—HTR1A—nervous system—attention deficit hyperactivity disorder	0.00063	0.0079	CbGeAlD
Methysergide—HTR1A—central nervous system—attention deficit hyperactivity disorder	0.000607	0.00761	CbGeAlD
Methysergide—HTR7—nervous system—attention deficit hyperactivity disorder	0.000602	0.00755	CbGeAlD
Methysergide—HTR1B—brain—attention deficit hyperactivity disorder	0.000597	0.00748	CbGeAlD
Methysergide—HTR1A—cerebellum—attention deficit hyperactivity disorder	0.000593	0.00744	CbGeAlD
Methysergide—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.000585	0.00733	CbGeAlD
Methysergide—HTR7—central nervous system—attention deficit hyperactivity disorder	0.00058	0.00727	CbGeAlD
Methysergide—HTR1D—brain—attention deficit hyperactivity disorder	0.000578	0.00725	CbGeAlD
Methysergide—HTR2C—brain—attention deficit hyperactivity disorder	0.000572	0.00717	CbGeAlD
Methysergide—HTR7—cerebellum—attention deficit hyperactivity disorder	0.000567	0.00711	CbGeAlD
Methysergide—Methylergometrine—DRD1—attention deficit hyperactivity disorder	0.000551	0.0564	CrCbGaD
Methysergide—SIGMAR1—brain—attention deficit hyperactivity disorder	0.000539	0.00676	CbGeAlD
Methysergide—HTR2B—brain—attention deficit hyperactivity disorder	0.000538	0.00674	CbGeAlD
Methysergide—HTR1A—brain—attention deficit hyperactivity disorder	0.000482	0.00604	CbGeAlD
Methysergide—HTR7—brain—attention deficit hyperactivity disorder	0.00046	0.00577	CbGeAlD
Methysergide—HTR2A—midbrain—attention deficit hyperactivity disorder	0.000457	0.00573	CbGeAlD
Methysergide—Lisuride—DRD4—attention deficit hyperactivity disorder	0.000436	0.0447	CrCbGaD
Methysergide—Bromocriptine—DRD4—attention deficit hyperactivity disorder	0.000404	0.0414	CrCbGaD
Methysergide—Lisuride—HTR1B—attention deficit hyperactivity disorder	0.000388	0.0397	CrCbGaD
Methysergide—Lisuride—DRD3—attention deficit hyperactivity disorder	0.000376	0.0385	CrCbGaD
Methysergide—HTR2A—nervous system—attention deficit hyperactivity disorder	0.000376	0.00471	CbGeAlD
Methysergide—Ergotamine—HTR1B—attention deficit hyperactivity disorder	0.000372	0.0381	CrCbGaD
Methysergide—Lisuride—DRD1—attention deficit hyperactivity disorder	0.000369	0.0378	CrCbGaD
Methysergide—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.000362	0.00453	CbGeAlD
Methysergide—Bromocriptine—HTR1B—attention deficit hyperactivity disorder	0.000359	0.0368	CrCbGaD
Methysergide—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.000353	0.00443	CbGeAlD
Methysergide—Bromocriptine—DRD3—attention deficit hyperactivity disorder	0.000349	0.0357	CrCbGaD
Methysergide—Lisuride—ADRA2A—attention deficit hyperactivity disorder	0.000343	0.0352	CrCbGaD
Methysergide—Bromocriptine—DRD1—attention deficit hyperactivity disorder	0.000342	0.035	CrCbGaD
Methysergide—Ergotamine—ADRA2A—attention deficit hyperactivity disorder	0.00033	0.0338	CrCbGaD
Methysergide—Bromocriptine—ADRA2A—attention deficit hyperactivity disorder	0.000318	0.0326	CrCbGaD
Methysergide—Methylergometrine—HTR2A—attention deficit hyperactivity disorder	0.0003	0.0307	CrCbGaD
Methysergide—HTR2A—brain—attention deficit hyperactivity disorder	0.000287	0.0036	CbGeAlD
Methysergide—Lisuride—DRD2—attention deficit hyperactivity disorder	0.00026	0.0267	CrCbGaD
Methysergide—Ergotamine—DRD2—attention deficit hyperactivity disorder	0.00025	0.0256	CrCbGaD
Methysergide—Bromocriptine—DRD2—attention deficit hyperactivity disorder	0.000241	0.0247	CrCbGaD
Methysergide—Lisuride—HTR2A—attention deficit hyperactivity disorder	0.000201	0.0206	CrCbGaD
Methysergide—Ergotamine—HTR2A—attention deficit hyperactivity disorder	0.000193	0.0198	CrCbGaD
Methysergide—Bromocriptine—HTR2A—attention deficit hyperactivity disorder	0.000186	0.0191	CrCbGaD
Methysergide—HTR7—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	4.39e-05	0.000229	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.38e-05	0.000229	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	4.38e-05	0.000229	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.35e-05	0.000228	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	4.35e-05	0.000228	CbGpPWpGaD
Methysergide—HTR2A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	4.34e-05	0.000227	CbGpPWpGaD
Methysergide—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	4.3e-05	0.000225	CbGpPWpGaD
Methysergide—HTR1B—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.3e-05	0.000225	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	4.29e-05	0.000225	CbGpPWpGaD
Methysergide—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	4.28e-05	0.000224	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.21e-05	0.00022	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	4.21e-05	0.00022	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	4.18e-05	0.000219	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.16e-05	0.000218	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	4.08e-05	0.000213	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	4.07e-05	0.000213	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	4.05e-05	0.000212	CbGpPWpGaD
Methysergide—HTR2A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	4.04e-05	0.000211	CbGpPWpGaD
Methysergide—HTR2B—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.04e-05	0.000211	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.01e-05	0.00021	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.98e-05	0.000208	CbGpPWpGaD
Methysergide—HTR1A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	3.98e-05	0.000208	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.98e-05	0.000208	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.97e-05	0.000207	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.96e-05	0.000207	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.96e-05	0.000207	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.95e-05	0.000207	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.95e-05	0.000207	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.95e-05	0.000206	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.94e-05	0.000206	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.94e-05	0.000206	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.92e-05	0.000205	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.89e-05	0.000203	CbGpPWpGaD
Methysergide—HTR1F—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	3.88e-05	0.000203	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.88e-05	0.000203	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.88e-05	0.000203	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.88e-05	0.000203	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.86e-05	0.000202	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.85e-05	0.000202	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.85e-05	0.000202	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.84e-05	0.000201	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.84e-05	0.000201	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.83e-05	0.0002	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.81e-05	0.000199	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.81e-05	0.000199	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.81e-05	0.000199	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.78e-05	0.000198	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	3.78e-05	0.000198	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.78e-05	0.000197	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.77e-05	0.000197	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.73e-05	0.000195	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.72e-05	0.000195	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	3.72e-05	0.000194	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.7e-05	0.000194	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.7e-05	0.000194	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.7e-05	0.000194	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	3.7e-05	0.000193	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.68e-05	0.000192	CbGpPWpGaD
Methysergide—HTR1E—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	3.66e-05	0.000192	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	3.65e-05	0.000191	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.64e-05	0.00019	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.62e-05	0.000189	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.61e-05	0.000189	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.6e-05	0.000188	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.59e-05	0.000188	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.58e-05	0.000187	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.57e-05	0.000187	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.57e-05	0.000187	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.56e-05	0.000186	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.55e-05	0.000186	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.55e-05	0.000185	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.54e-05	0.000185	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	3.53e-05	0.000184	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.53e-05	0.000184	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.52e-05	0.000184	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.5e-05	0.000183	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.5e-05	0.000183	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.49e-05	0.000182	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.48e-05	0.000182	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.48e-05	0.000182	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.48e-05	0.000182	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.47e-05	0.000182	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.46e-05	0.000181	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	3.45e-05	0.00018	CbGpPWpGaD
Methysergide—HTR2A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	3.44e-05	0.00018	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.43e-05	0.000179	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.42e-05	0.000179	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.4e-05	0.000178	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	3.4e-05	0.000178	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.38e-05	0.000177	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.38e-05	0.000177	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.37e-05	0.000177	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.36e-05	0.000176	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	3.33e-05	0.000174	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	3.29e-05	0.000172	CbGpPWpGaD
Methysergide—HTR1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.28e-05	0.000171	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.27e-05	0.000171	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.26e-05	0.000171	CbGpPWpGaD
Methysergide—HTR2C—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.26e-05	0.000171	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.25e-05	0.00017	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.24e-05	0.00017	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.24e-05	0.00017	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	3.23e-05	0.000169	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.23e-05	0.000169	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.22e-05	0.000168	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.22e-05	0.000168	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	3.21e-05	0.000168	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	3.2e-05	0.000168	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	3.19e-05	0.000167	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.18e-05	0.000166	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.15e-05	0.000165	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	3.1e-05	0.000162	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	3.05e-05	0.00016	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.02e-05	0.000158	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	3.01e-05	0.000158	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3e-05	0.000157	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.97e-05	0.000156	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.96e-05	0.000155	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	2.95e-05	0.000154	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.95e-05	0.000154	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	2.94e-05	0.000154	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.93e-05	0.000153	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	2.92e-05	0.000153	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	2.92e-05	0.000153	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	2.92e-05	0.000152	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	2.91e-05	0.000152	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.88e-05	0.00015	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	2.87e-05	0.00015	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.86e-05	0.00015	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	2.86e-05	0.00015	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.84e-05	0.000149	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.82e-05	0.000148	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.82e-05	0.000148	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	2.81e-05	0.000147	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.81e-05	0.000147	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.81e-05	0.000147	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.74e-05	0.000143	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.73e-05	0.000143	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.69e-05	0.000141	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.69e-05	0.000141	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.67e-05	0.00014	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.66e-05	0.000139	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.64e-05	0.000138	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.64e-05	0.000138	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.63e-05	0.000138	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.62e-05	0.000137	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.61e-05	0.000137	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	2.61e-05	0.000136	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.6e-05	0.000136	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.58e-05	0.000135	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.56e-05	0.000134	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.55e-05	0.000133	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	2.54e-05	0.000133	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	2.53e-05	0.000132	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.5e-05	0.000131	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.5e-05	0.000131	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.48e-05	0.00013	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.48e-05	0.00013	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	2.48e-05	0.00013	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.46e-05	0.000129	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.45e-05	0.000128	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.44e-05	0.000127	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.43e-05	0.000127	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.4e-05	0.000126	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.39e-05	0.000125	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.37e-05	0.000124	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.35e-05	0.000123	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.35e-05	0.000123	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.34e-05	0.000122	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.29e-05	0.00012	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.28e-05	0.00012	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.28e-05	0.000119	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.27e-05	0.000119	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.27e-05	0.000119	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.26e-05	0.000118	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.26e-05	0.000118	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.23e-05	0.000117	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.21e-05	0.000116	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.19e-05	0.000114	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.19e-05	0.000114	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.17e-05	0.000114	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.15e-05	0.000112	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.13e-05	0.000111	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.12e-05	0.000111	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.12e-05	0.000111	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.1e-05	0.00011	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.08e-05	0.000109	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.08e-05	0.000109	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.08e-05	0.000109	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.07e-05	0.000109	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.07e-05	0.000109	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.07e-05	0.000108	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.06e-05	0.000108	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.06e-05	0.000108	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.06e-05	0.000108	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.04e-05	0.000107	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.02e-05	0.000106	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2e-05	0.000105	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2e-05	0.000104	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.99e-05	0.000104	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.98e-05	0.000104	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.97e-05	0.000103	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.93e-05	0.000101	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.92e-05	0.0001	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.91e-05	0.0001	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.9e-05	9.95e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.9e-05	9.95e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.88e-05	9.82e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.86e-05	9.74e-05	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.85e-05	9.69e-05	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.84e-05	9.64e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.75e-05	9.15e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.74e-05	9.11e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.73e-05	9.07e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.72e-05	9.01e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.68e-05	8.8e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.67e-05	8.75e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.62e-05	8.47e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.61e-05	8.43e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.57e-05	8.21e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.56e-05	8.16e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.54e-05	8.07e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.53e-05	8.03e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.52e-05	7.97e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.52e-05	7.93e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.51e-05	7.87e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.42e-05	7.42e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.41e-05	7.38e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.4e-05	7.32e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.36e-05	7.09e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.34e-05	7.02e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.34e-05	7.01e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.33e-05	6.97e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.33e-05	6.97e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.32e-05	6.88e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.3e-05	6.82e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.23e-05	6.41e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.23e-05	6.41e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.1e-05	5.77e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.04e-05	5.45e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.94e-06	5.2e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.89e-06	5.17e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.11e-06	3.72e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.1e-06	3.72e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.06e-06	3.69e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.91e-06	3.62e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.49e-06	3.4e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.26e-06	2.75e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.24e-06	2.74e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.55e-06	2.38e-05	CbGpPWpGaD
